title: Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.
authors.forename: H
authors.initials: H
authors.lastname: Alchalby
authors.forename: M
authors.initials: M
authors.lastname: Lioznov
authors.forename: U
authors.initials: U
authors.lastname: Fritzsche-Friedland
authors.forename: A
authors.initials: A
authors.lastname: Badbaran
authors.forename: T
authors.initials: T
authors.lastname: Zabelina
authors.forename: U
authors.initials: U
authors.lastname: Bacher
authors.forename: T
authors.initials: T
authors.lastname: Stübig
authors.forename: F A
authors.initials: FA
authors.lastname: Ayuk
authors.forename: A R
authors.initials: AR
authors.lastname: Zander
authors.forename: N
authors.initials: N
authors.lastname: Kröger
mesh_terms: D000328:Adult; D000368:Aged; D018952:Antigens, CD34 / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000097:blood* / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D011379:Prognosis; D012189:Retrospective Studies; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous
chemical_list: D018952:Antigens, CD34